AAIPharma Services Corp./Cambridge Major Laboratories Increases Capacity At Wilmington, North Carolina, Manufacturing Facility
"Our facility upgrades in Wilmington for Drug Product complement the overall progress of our laboratory and headquarters expansions. We are excited to have this top of the line equipment and added capability for specialized areas of drug product development and manufacturing," stated Ted Dolan, COO.
According to company officials. “these investments have been driven by the significant growth in our drug product portfolio, particularly for orphan drugs and rare disease therapies. AAI/CML will continue to invest in unique capabilities and facility upgrades as its portfolio expands."
“Some of the recent additions to our oral solid capabilities include precision coating for our fluid bed dryer, which allows for bottom spray coating for enteric release products,” officials explained.
“Also, it allows top spray granulatation and drying for materials from the high shear mixer. The additional bottom spray coating capability was introduced along with the extruder spheronizer. Lastly, a Bosch KKE 1700 capsule checkweighter was added to increase the encapsulation capabilities. With the addition of this equipment and a second manufacturing shift, the solid dosage capacity has increased by approximately 35%,” officials explained.
Supply Chain Bottlenecks Creating New “Logistical Hotspots”
The “Great Resignation” Is Impacting Corporate Relocations
Workforce Q4 2021
Changes in the Incentives Landscape
2020 Top States for Doing Business Showcase Their Pro-Business Environments
2021 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
How an International Business Can Enter the U.S. Market Via M&A